Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
595 JPY | -1,82% |
|
+2,06% | -49,23% |
31/05 | JCR Pharmaceuticals' winst over het hele jaar met 46% gestegen | MT |
27/05 | JCR PHARMACEUTICALS CO., LTD. : Jefferies & Co. is Neutraal over het aandeel | ZM |
ETF's gepositioneerd op JCR Pharmaceuticals Co., Ltd.
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.67% | 19 M€ | +3,60% | - | |
0.30% | 14 M€ | +13,80% | ||
0.07% | 57 M€ | +21,21% | ||
0.04% | 69 M€ | +18,15% | ||
0.03% | 17 M€ | +18,02% | - | |
0.02% | 4 931 M€ | +19,26% | ||
0.02% | 9 764 M€ | +19,73% | ||
0.02% | 19 753 M€ | +17,87% | - | |
0.02% | 138 841 M€ | +19,11% | ||
0.01% | 775 M€ | -.--% | - | |
0.01% | 7 M€ | +4,79% | - | |
0.00% | 10 M€ | -3,35% | - | |
0.00% | 35 M€ | +5,33% | - | |
0.00% | 36 M€ | +10,49% | - | |
0.00% | 414 M€ | +11,89% | - | |
0.00% | 40 M€ | +6,68% | - | |
0.00% | 324 M€ | +8,40% | - | |
0.00% | 32 M€ | +4,28% | - |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-49,23% | 461 mln. | |
+55,19% | 801 mld. | |
+47,26% | 631 mld. | |
-6,09% | 359 mld. | |
+21,92% | 337 mld. | |
+18,40% | 245 mld. | |
+3,64% | 231 mld. | |
+12,98% | 219 mld. | |
+10,86% | 171 mld. | |
-2,78% | 161 mld. |
- Beurs
- Aandelen
- Koers 4552
- ETF's JCR Pharmaceuticals Co., Ltd.